Reader View AI Reader View Vanda Pharmaceuticals settles patent litigation with MSN over HETLIOZ LQ generic www.investing.com · November 20, 2026 · 12:16 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link